RY 163.5 0.2883% SHOP 126.29 6.5918% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 85.7 0.1168% ENB 63.3 0.0% BN 70.81 2.3414% TRI 252.68 0.3256% CNQ 40.22 -0.7404% CP 101.28 0.556% CNR 135.72 0.6004% BMO 130.65 0.4382% BNS 67.27 0.0% CSU 4769.9702 2.7097% CM 83.55 1.1012% MFC 41.32 2.3026% ATD 73.15 0.0% NGT 73.7 -2.1768% TRP 67.91 0.1918% SU 48.71 -0.5106%
Company Overview: West Red Lake Gold Mines Ltd. (TSXV: WRLG) is a Canada-based mineral exploration company dedicated to advancing and developing its flagship Madsen Gold Mine. The company’s operations span a 47-square-kilometer land package in Ontario’s Red Lake district, a region known for its rich gold deposits. Unicycive Therapeutics Inc. (NASDAQ: UNCY) is a biotechnology company focused on developing innovative treatments for kidney-related diseases. The company is dedicated to addressing unmet medical needs in nephrology through its targeted therapeutic pipeline. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
As of April 3, 2025, major U.S. equity indices posted notable week-to-date (WTD) losses amid broad-based selling pressure. The S&P 500 closed at 5,396.52, down 3.30% for the week. The NASDAQ Composite, weighed down by weakness in the technology sector, declined 4.46%, ending at 16,550.60. The Russell 2000 underperformed, falling 5.58% WTD to close at 1,910.55.
In Canada, the S&P/TSX Venture Composite Index (TSX: ^JX) extended its downward momentum throughout the week, closing at 614.28 on April 3, 2025, marking a 3.05% week-to-date (WTD) loss. On Thursday, broad-based sector weakness including consumer non-cyclicals, consumer cyclicals, technology, real estate, energy, industrials, healthcare, financials, and basic materials contributed to the overall decline in market performance.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.